OKYO - MCAP CO - OKYO Pharma Limited

The OKYO Pharma Limited (OKYO) price chart on the GURU.Markets platform illustrates the price action of an asset whose operations are based on creating advanced peptide drugs for the treatment of the cornea and dry eye. The current indicator is 0.07. The business targets the mass market, overcoming dependence on a single product through the final stages of testing. Additionally, OKYO Pharma Limited (OKYO) is implementing "green" standards within its laboratory operations.

The integration of ESG standards and eco-design into the ophthalmology operations of OKYO Pharma Limited (OKYO) is reflected in the business valuation dynamics. The change in the company's market capitalization demonstrates the aggregate value of all outstanding shares. This aggregate is calculated by multiplying the current share price by the total number of securities. This metric allows investors to differentiate short-term volatility from a systemic crisis of the business model. Analyzing historical boundaries helps the investor assess the asset's resilience to market drawdowns.